TFF Pharmaceuticals Inc.
0.07
-0.09 (-56.98%)
At close: Dec 12, 2024, 9:00 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -21.24M -31.77M -31.04M -18.57M -11.87M -3.84M -178.60K -370.37K
Depreciation & Amortization 502.48K 388.22K 111.45K n/a n/a n/a n/a n/a
Stock-Based Compensation 2.93M 4.25M 3.55M 2.19M 590.04K n/a n/a n/a
Other Working Capital 1.49M 364.95K -2.39M -1.10M 51.62K -12.06K n/a n/a
Other Non-Cash Items 288.70K 5.04M 6.19M 1.32M 577.59K 930.88K 9.14K -10.98K
Deferred Income Tax -38.38K -5.04M -6.19M n/a n/a n/a n/a n/a
Change in Working Capital 1.53M -212.15K -2.18M -235.50K 64.06K 386.12K -9.14K 10.98K
Operating Cash Flow -16.04M -27.34M -29.56M -16.62M -11.22M -2.13M -187.75K -359.39K
Capital Expenditures -94.75K -1.55M -868.50K -1.10M n/a n/a n/a n/a
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow -94.75K -1.55M -868.50K -1.10M n/a n/a n/a n/a
Debt Repayment n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a -875.36K n/a n/a n/a
Other Financial Acitivies -108.70K 110.82K 869.97K 714.38K 8.07M 12.39M 187.75K 359.39K
Financial Cash Flow 5.01M 11.75M 28.88M 24.99M 29.05M 12.39M 187.75K 359.39K
Net Cash Flow -11.13M -17.18M -1.51M 7.21M 17.83M 10.26M n/a n/a
Free Cash Flow -16.13M -28.89M -30.43M -17.72M -11.22M -2.13M -187.75K -359.39K